Pikamilone Powder CAS 34562-97-5 Nootropics Pikamilone Purity Pikamilone

• Customization: Available
• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Sample: Available
• OEM: Available
• MOQ: 1kg
• CAS: 34562-97-5
• Keyword: Pikamilone
• Keyword 1: Pikamilone Powder
• Transport Package: 1kg Foil Bag /25kg Drum
• Specification: 99%
• Trademark: /
• Origin: China
• Production Capacity: 20000

Product Description

Description

Picamilon is a dietary supplement and nootropic drug. It is a combination of Vitamin B3, also known as niacin, and the neurotransmitter GABA. This supplement is taken orally, typically in powder or tablet form, and is able to cross the blood-brain barrier. Once in the brain, it is hydrolyzed into GABA and niacin.

The function of picamilon is two-fold, since, when the compound is broken down into its constituent parts in the brain, each one has a different effect. Niacin acts as a vasodilator, which enlarges the blood vessels of the brain. This, in turn, leads to increased blood flow, reduced blood pressure, and is thought to assist in the management of migraine headache pain.

When the second part of the picamilon compound, GABA, is activated in the brain, it is a believed to create a moderate anti-anxiety effect. This is known as an anxiolytic response, and is due to that fact that GABA is an inhibitory neurotransmitter. GABA limits, rather than encourages, certain brain functions.

Product name	Pikamilone
Appearance	white Powder
Specification	99%
Shelf life	2 years when properly stored

Function and Application

1. Picamilon can produce an anxiolytic response which decreases anxiety.

2. Picamilon is used to treat Asthenia, which results in increase muscle strength.

3. Picamiloon can enhance learning and memory.

4. Picamilon is used to treat depression.

5. Picamilon is effective for treatment of migraine and other headaches.

6. Picamilon is helpful with the misuse of alcohol and treatment of hangovers.

7. Treatment of Violations of cerebral blood flow (ischemic acute, subacute and rehabilitation period of ischemic stroke, chronic insufficiency of cerebral blood flow);